Category Archives: CooperVision Contact Lenses

Featured Stories

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

Dozens Receive Nonsterile Simulated Saline Solution

Dozens-Receive-Nonsterile-Simulated-Saline-Solution

The FDA said last week that more than 40 patients had received intravenous simulated saline that was not sterile and was not intended for human use.

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

CooperVision Avaira Sphere Contact Lens Recall Most Serious Type, FDA Says

Federal regulators have deemed CooperVision Inc.’s expanded Avaira Sphere contact lens recall a Class I recall, according to an announcement from the U.S. Food & Drug Administration (FDA). The expanded recall, which was announced on November 15, involved CooperVision’s Avaira … Continue reading

Posted in CooperVision Contact Lenses, Defective Medical Devices |

CooperVision Adds 6 Million Avaira Sphere Lenses to Contact Lens Recall

CooperVision Inc. is expanding its recent contact lens recall to include to an additional brand. With the expansion, the < "http://www.yourlawyer.com/topics/overview/coopervision-avaira-topic-contact-lens-recall-eye-injury-lawyers">CooperVision contact lens recall now includes an additional 6 million lenses sold under the Avaira Sphere brand name. In October, … Continue reading

Posted in CooperVision Contact Lenses, Defective Medical Devices |

CooperVision Avaira Toric Contact Lens Recall Most Serious Type, FDA Says

CooperVision Inc.’s recent recall of Avaira Toric contact lenses has been deemed Class 1 by the U.S. Food & Drug Administration (FDA). Class 1 recalls are the FDA’s most serious type of recall, and means the agency has determined there … Continue reading

Posted in CooperVision Contact Lenses, Defective Medical Devices |

FDA Threat Prompts CooperVision to Reannounce Avaira Toric Contact Lens Recall

Pressure from U.S health regulators finally prompted CooperVision Inc. to step up its efforts to get the word out about its recent < "http://www.yourlawyer.com/topics/overview/coopervision-avaira-topic-contact-lens-recall-eye-injury-lawyers">recall of Avaira Toric contact lenses. According to a report from MSNBC, CooperVision is also acknowledging that … Continue reading

Posted in CooperVision Contact Lenses |

CooperVision Quietly Recalled Contact Lenses Amid Reports of Torn Corneas, Vision Problems

While contact lens wears were suffering from blurry vision and agonizing pain that, in some cases, led to emergency room hospital visits, CooperVision was recalling < "http://www.yourlawyer.com/topics/overview/coopervision-avaira-topic-contact-lens-recall-eye-injury-lawyers">Avaira Toric contact lenses in what one popular blogger described as a “stealth recall.” … Continue reading

Posted in CooperVision Contact Lenses |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.